•  
  •  
  •  
  •  

2025-10-02 02:53:43

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Hero MotoCorp Ltd dispatches 687,220 units in September 2025
  • Synbiotics Ltd's Amphotericin B Manufacturing Facility receives USFDA approval
  • Veefin has successfully integrated CRIF's Strategy One BRE with our no-code Digital Lending Stack
  • Sentynl Therapeutics updates on its NDA for CUTX-101
  • Unimech Aerospace and Manufacturing Ltd experiences slowdown in revenue

Keywords Selected:  PanaceaBiotec

Stock Report

  • Panacea Biotec Launches India's first 100% toxin-free and safe NikoMom Baby Skin Care
  • Panacea Biotec Ltd updates on arbitration settlement with Apotex Inc
  • Panacea Biotec Ltd receives additional award from UNICEF for supply of bOPV
  • Panacea Biotec Pharma Ltd launches baby daipers and wipes under brand name 'NikoMom'
  • Panacea Biotec receives LoA from UNICEF for supply of 115 million doses of bOPV
  • DFC Commits US$20 Million Long-Term Loan to Panacea Biotec Towards Capacity-Expansion Project for Hexavalent Vaccine
  • Panacea Biotec launches EasyFourPol® in India and receives registration of Valganciclovir Powder for Oral Solution in Germany
  • Panacea Biotec Ltd Q1 FY2024 consolidated PAT at Rs. 10.98 crore
  • Panacea Biotec launches new range of pediatric food and nutritional products in India
  • Panacea Biotec Ltd Q3 FY2023 consolidated net profit up at Rs. 19.37 crores
  • Panacea Biotec donates 125,000 doses of Easyfive-TT to Ministry of Health, Republic of Cuba for use in the National Health System
  • Panacea Biotec receives UNICEF & PAHO awards for supply of Pentavalent Vaccine
  • Panacea Biotec Pharma Ltd's Baddi plant classified as OAI by USFDA
  • Panacea Biotec Ltd consolidated Q1 FY2022-23 loss at Rs. 56.14 crores
  • Panacea Biotec Ltd Q4FY22 consolidated PAT at Rs. 1237.47 crores
  • Panacea Biotec Ltd appoints additional director
  • Panacea Biotec Ltd announces resignation of Non-Executive Nominee Director
  • Mankind Pharma acquires Panacea Biotec's Domestic Pharmaceutical Formulation Brands
  • CEPI, THSTI and Panacea Biotec partner to develop broadly protective Betacoronavirus vaccines
  • Panacea Biotec posts consolidated loss of Rs. 49.20 crores in Q3FY22
  • Panacea Biotec Pharma Ltd to sell domestic business assets for Rs. 1908 crore
  • Panacea Biotec to consider fund raising on Feb 1, 2022
  • Panacea Biotec Ltd consolidated Q2 FY2021-22 loss at Rs. 53.01 crore

Latest Post

  • Hero MotoCorp Ltd dispatches 687,220 units in September 2025
  • Synbiotics Ltd's Amphotericin B Manufacturing Facility receives USFDA approval
  • Veefin has successfully integrated CRIF's Strategy One BRE with our no-code Digital Lending Stack
  • Sentynl Therapeutics updates on its NDA for CUTX-101
  • Unimech Aerospace and Manufacturing Ltd experiences slowdown in revenue


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024